Treace Medical Concepts, Inc. TMCI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$17.96M-91.2% | -$9.39M+42.3% | -$16.29M+6.4% | -$17.4M-9.3% | -$15.92M-3,078% | ||
| $899K-68.0% | $2.81M+1.1% | $2.78M+7.8% | $2.58M+4.7% | $2.46M+10.0% | ||
| $8.03M+6.3% | $7.56M-5.5% | $8M-16.5% | $9.58M+10.2% | $8.69M+1.6% | ||
| $262K+280% | $69K-8.0% | $75K+1.4% | $74K0.0% | $74K-1.3% | ||
| —— | —— | —— | —— | —— | ||
| -$11.69M-223% | $9.52M+272% | $2.56M+467% | -$696K+92.5% | -$9.29M-154% | ||
| $335K+106% | -$5.39M-454% | -$973K-122% | $4.46M+439% | -$1.32M— | ||
| $6.81M+173% | -$9.38M-143% | -$3.86M-157% | $6.74M+149% | $2.7M+133% | ||
| -$3.13M— | —— | —— | —— | -$6.17M— | ||
| $293K+46.5% | $200K— | —— | $289K+280% | $76K+322% | ||
| -$235K— | —— | -$36K— | —— | -$57K+41.2% | ||
| -$854K-3.5% | -$825K+0.5% | -$829K-7.9% | -$768K+2.2% | -$785K+66.3% | ||
| $7.24M+190% | -$8.03M+11.7% | -$9.09M-198% | -$3.05M-173% | $4.2M+200% | ||
| $3.06M+27.7% | $2.4M-14.6% | $2.81M-41.1% | $4.77M+34.5% | $3.54M+15.3% | ||
| $16.07M+183% | $5.68M+22.5% | $4.64M-69.4% | $15.16M+0.5% | $15.09M-19.3% | ||
| -$7.82M-181% | $9.67M+10.6% | $8.74M+368% | -$3.26M-72.0% | -$1.89M-155% | ||
| $91K+30.0% | $70K-71.0% | $241K+108% | $116K-2.5% | $119K+109% | ||
| $207K+176% | $75K-81.8% | $412K+2,843% | $14K-96.5% | $401K+1,194% | ||
| $6K— | —— | —— | —— | $0— | ||
| -$588K-143% | $1.38M— | $0-100% | $987K+450% | -$282K-1,185% | ||
| -$1.16M— | —— | -$366K+93.1% | -$5.32M-363% | $2.02M+366% | ||
| $858K-31.0% | $1.24M-1.3% | $1.26M-0.6% | $1.27M+3.0% | $1.23M+0.5% | ||
| -$5K-225% | $4K-20.0% | $5K-86.5% | $37K-51.9% | $77K-66.1% | ||
| $262K+280% | $69K-8.0% | $75K+1.4% | $74K0.0% | $74K-1.3% | ||
| —— | $684.25K0.0% | $684.25K0.0% | $684.25K0.0% | $684.25K— | ||
| -$854K-3.5% | -$825K+0.5% | -$829K-7.9% | -$768K+2.2% | -$785K+66.3% | ||
| -$608K+12.8% | -$697K-213% | $615K— | —— | -$1.37M-1.6% | ||
| $571K+7.1% | $533K-4.1% | $556K+0.2% | $555K-4.0% | $578K-66.8% | ||
| -$587K-28.2% | -$458K+13.7% | -$531K-1,559% | -$32K+82.9% | -$187K+47.8% | ||
| $6K— | —— | —— | —— | $0— | ||
| $466K+13.9% | $409K0.0% | $409K+317% | $98K— | $0— | ||
| —— | $14.08M0.0% | $14.08M0.0% | $14.08M0.0% | $14.08M— | ||
| -$854K-3.5% | -$825K+0.5% | -$829K-7.9% | -$768K+2.2% | -$785K+66.3% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $497K+39.6% | $356K-32.1% | $524K+186% | $183K+307% | $45K— | ||
| $4.18M+140% | -$10.42M+12.4% | -$11.9M-52.2% | -$7.82M-1,293% | $655K+109% | ||
| $4.18M+140% | -$10.42M+12.4% | -$11.9M-52.2% | -$7.82M-1,293% | $655K+109% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Treace Medical Concepts, Inc. generate?
- Treace Medical Concepts, Inc. (TMCI) generated -$12.9M in operating cash flow over the trailing twelve months.
- What is Treace Medical Concepts, Inc.'s free cash flow?
- After $13.0M of capital expenditures, Treace Medical Concepts, Inc.'s free cash flow was -$26.0M over the trailing twelve months, up 29.8% year over year.
- Where does Treace Medical Concepts, Inc.'s cash flow data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
